GLENMARK PHARMACEUTICALS LTD. - 532296 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Change in Senior Management14-09-2023
14-09-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We are enclosing herewith copies of the newspaper advertisement published in Financial Express (English) and Loksatta (Marathi)06-09-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Intimation For Book Closure
The Register of Members and Share Transfer Books of the Company will remain closed from 19 September 2023 to 29 September 2023 (both dates inclusive) for ascertaining the names of the Shareholders to whom dividend if declared at the AGM is payable.04-09-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Business Responsibility and Sustainability Reporting (BRSR)
We are enclosing herewith Business Responsibility and Sustainability Report of the Company for the F.Y. 2022-23.04-09-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Reg. 34 (1) Annual Report.
Pursuant to Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the Integrated Annual Report for the Financial Year 2022-23.04-09-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Notice Of 45Th Annual General Meeting Of The Company For F.Y. 2022-23
45th Annual General Meeting is scheduled to be held on Friday, 29 September 2023 at 02:00 p.m. The Notice of the same is attached as reference.04-09-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Intimation Of The Date Of 45Th Annual General Meeting And Book Closure Pursuant To Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
The 45th Annual General Meeting of Members of the Company is scheduled to be held on Friday, September 29, 2023 at 2.00 p.m. through Video Conferencing and Other Audio Visual Means.25-08-2023
Neutral Glenmark Pharma; target of Rs 780: Motilal Oswal
Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 780 in its research report dated August 14, 2023.22-08-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Update
Press Release of our wholly owned subsidiary company relating to Antitrust settlement with DOJ22-08-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
The transcript of the Earnings Call held on Monday, August 14, 2023 for the first quarter ended June 30, 2023 has been uploaded on the Company''s website.21-08-2023